-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULAR THERAPEUTIX SHARES DOWN 27% PREMARKET AFTER CO REPORTS LATE‑STAGE EYE‑DISEASE TRIAL DATA

Reuters·02/17/2026 12:04:25

Please log in to view news